EP2991671 - Bibliographic data
DOSAGE PAR VOIE ORALE DE COMPOSÉS GLP-1
| Last update | 16/06/2025 |
|---|---|
| Legal status | Brevet EP révoqué |
| Origin | Euro-PCT |
| (73) Holder |
Novo Nordisk A/S Novo Allé
2880 Bagsværd
Danemark
|
|---|---|
| (72) Inventors |
Flemming Seier NIELSEN Novo Allé
DK-2880 Bagsværd
Danemark
Per SAUERBERG Novo Allé
DK-2880 Bagsværd
Danemark
|
| (74) Agent |
Mail recipient
DENNEMEYER & ASSOCIATES S.A. 55, Rue des bruyères
L-1274
HOWALD
Luxembourg
|
| (21) Request number | EP14721834.1 |
|---|---|
| (22) Request date | 02/05/2014 |
| (11) Publication number | EP2991671 |
|---|---|
| Publication date | 15/08/2018 |
| (54) Title of the invention | DOSAGE PAR VOIE ORALE DE COMPOSÉS GLP-1 |
|---|---|
| (51) International classification | A61K 38/26, A61P 3/10 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 13166205 |
|---|---|
| Initial application | None |
| Divisional application | EP18188817.3 /EP3485900 None |
| Expected annuity | Annuity: 11 - Amount: 230 € - Due date 31/05/2024 |
|---|---|
| Last annuity | Annuity: 10 - Payment date 21/04/2023 |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 15/08/2018 Constitution de mandataire pour un dossier - Legal date 03/10/2018 Révocation du brevet européen - Legal date 05/12/2023 |